Personalization Through Genetic Testing and Menopause Response Not all women respond identically to GLP-1 therapy during menopause
Naqvi will review your health history, goals, and treatment tolerance before recommending a plan
While NAD+ precursors (like NMN or NR) aim to increase NAD+ levels directly, 5-Amino-1MQ is studied for its upstream regulatory approachpotentially increasing NAD+ by blocking its consumption rather than adding more precursors
Interestingly, the GLP-1R/GLP-2R dual agonist dapiglutide is being investigated in the DREAM Trial (NCT05788601) to lower body weight and low-grade inflammation in obesity
CoreAge Rx Our highest-rated GLP-1 weight loss program Fella Health Starting at $199/month Want to compare options
Most patients experience rapid improvement in both appearance and discomfort, especially for painful, deep-seated breakouts